SAKAR HEALTHCARE
|
SAKAR HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Operational & Financial Ratios | ||||
Earnings Per Share (Rs) | 6.70 | 8.87 | 6.84 | 6.43 |
CEPS(Rs) | 14.57 | 14.52 | 12.00 | 11.16 |
DPS(Rs) | - | - | - | - |
Book NAV/Share(Rs) | 91.04 | 74.45 | 63.04 | 54.35 |
Tax Rate(%) | 24.91 | 19.82 | 19.27 | 21.30 |
Margin Ratios | ||||
Core EBITDA Margin(%) | 24.95 | 22.88 | 23.87 | 23.56 |
EBIT Margin(%) | 17.21 | 17.03 | 16.60 | 17.46 |
Pre Tax Margin(%) | 12.74 | 14.76 | 13.97 | 14.73 |
PAT Margin (%) | 9.57 | 11.84 | 11.28 | 11.60 |
Cash Profit Margin (%) | 20.80 | 19.38 | 19.78 | 20.13 |
Performance Ratios | ||||
ROA(%) | 4.22 | 6.81 | 7.30 | 8.36 |
ROE(%) | 8.48 | 13.44 | 11.88 | 11.83 |
ROCE(%) | 8.95 | 12.09 | 13.16 | 14.79 |
Asset Turnover(x) | 0.44 | 0.58 | 0.65 | 0.72 |
Sales/Fixed Asset(x) | 0.49 | 0.79 | 1.12 | 1.05 |
Working Capital/Sales(x) | 93.66 | 39.47 | 208.68 | 11.18 |
Efficiency Ratios | ||||
Fixed Capital/Sales(x) | 2.03 | 1.27 | 0.89 | 0.95 |
Receivable days | 49.62 | 37.80 | 39.70 | 36.22 |
Inventory Days | 40.48 | 42.53 | 51.30 | 48.09 |
Payable days | 140.43 | 123.30 | 90.05 | 46.13 |
Valuation Parameters | ||||
PER(x) | 29.94 | 15.24 | 16.54 | 7.77 |
PCE(x) | 13.77 | 9.31 | 9.43 | 4.47 |
Price/Book(x) | 2.20 | 1.82 | 1.79 | 0.92 |
Yield(%) | - | - | - | - |
EV/Net Sales(x) | 3.76 | 2.53 | 2.31 | 1.10 |
EV/Core EBITDA(x) | 13.20 | 10.29 | 9.21 | 4.22 |
EV/EBIT(x) | 21.83 | 14.84 | 13.93 | 6.29 |
EV/CE(x) | 1.49 | 1.21 | 1.23 | 0.79 |
M Cap / Sales | 2.86 | 1.80 | 1.86 | 0.90 |
Growth Ratio | ||||
Net Sales Growth(%) | 4.00 | 35.35 | 14.17 | - |
Core EBITDA Growth(%) | 20.42 | 32.47 | 10.29 | - |
EBIT Growth(%) | 5.09 | 38.88 | 8.57 | - |
PAT Growth(%) | -15.95 | 42.10 | 11.01 | - |
EPS Growth(%) | -24.44 | 29.65 | 6.34 | - |
Financial Stability Ratios | ||||
Total Debt/Equity(x) | 0.69 | 0.73 | 0.43 | 0.20 |
Current Ratio(x) | 1.03 | 1.07 | 1.01 | 1.52 |
Quick Ratio(x) | 0.74 | 0.77 | 0.54 | 0.75 |
Interest Cover(x) | 3.85 | 7.51 | 6.30 | 6.41 |
Total Debt/Mcap(x) | 0.31 | 0.40 | 0.24 | 0.22 |
Compare Financial Ratios of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹701.7 Cr | 5.4% | 6.6% | -8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,483.0 Cr | 0.4% | 5.1% | 64.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹136,472.0 Cr | 2.1% | 3.9% | 42.8% | Stock Analytics | |
CIPLA | ₹130,171.0 Cr | -2.1% | 3.7% | 30.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,298.0 Cr | -2.9% | -3.7% | 20.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹110,736.0 Cr | -1% | -13.6% | 81.7% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | 5.4% |
6.6% |
-8.9% |
SENSEX | -1.4% |
3.3% |
25.2% |
You may also like the below Video Courses